We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Bio-Engineered Implant Helps Heal Torn ACLs

By HospiMedica International staff writers
Posted on 11 Jan 2021
Print article
Image: An ECM implant repairs a torn ACL (Photo courtesy of Miach Orthopaedics)
Image: An ECM implant repairs a torn ACL (Photo courtesy of Miach Orthopaedics)
A novel implant acts as a biological bridge between the two ends of a torn anterior cruciate ligament (ACL) to facilitate healing.

The Miach Orthopaedics (Westborough, MA, USA) Bridge-Enhanced ACL Repair (BEAR) implant is designed to restore natural anatomy and function of the knee. The implant, which is comprised of a proprietary blend of extracellular matrix (ECM) proteins and collagen, is stitched into place during arthroscopy between the torn ends of the ACL and then injected with the patient’s blood, which clots in the implant. The BEAR is held in place long enough for the body to heal the torn ends of the ACL back together, while maintaining its original attachments to the femur and tibia. As the ACL heals, the BEAR implant is absorbed by the body, within approximately eight weeks.

Unlike surgical ACL reconstruction, which is the current standard of care, the implant does not require a second surgical wound site to remove a healthy tendon from another part of the leg, or implanting a deceased donor's tendon. The BEAR implant is indicated for skeletally mature patients at least 14 years of age with a complete rupture of the ACL, as confirmed by magnetic resonance imaging (MRI). Patients must have an ACL stump attached to the tibia to construct the repair, and the device must be implanted within 50 days of injury.

“Preserving a patient's native ACL instead of replacing it with a graft has long been a goal of surgeons, and before the BEAR implant, multiple approaches were studied and failed,” said Martha Shadan, CEO and president of Miach Orthopaedics. “The BEAR implant, which is the first medical technology to show that it enables a patient's own torn ACL to heal, represents the first substantial advancement in the treatment of ACL tears in decades, and has the potential to change the standard of care.”

The ACL is a broad, thick collagen cord that originates on the anterior portion of the femur in the intercondylar notch and inserts on the posterior aspect of the tibial plateau. The ACL guides the tibia through a normal, stable range of motion, along the end of the femur, maintaining joint stability. The ligament is unfortunately poorly vascularized, and thus has no ability to heal itself after a complete tear, leading to further destruction of the articular and meniscal cartilage over time.

Related Links:
Miach Orthopaedics

Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Vital Signs Monitor
Aurus 10

Print article

Channels

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.